Market Cap

Mind Medicine MindMed, Inc. Market Capitalization:

C$217.3 Million

CAD as of Jan. 1, 2024

US$164.0 Million

business Mind Medicine MindMed, Inc. Company Profile

No stock data available

Market Capitalization History of Mind Medicine MindMed, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Mind Medicine MindMed, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 C$217.3 M 20.25%
Jan. 1, 2023 C$180.7 M 213.57%
Jan. 1, 2022 C$57.6 M -63.16%
Jan. 1, 2021 C$156.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Sell the task first.
Automate what repeats.
Publish a paid offer in minutes. Learn what buyers actually pay for before building agents, workflows, or services nobody buys.
Get Started Free
For AI operators, consultants, & service builders

Mind Medicine MindMed, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Mind Medicine MindMed, Inc. has the following listings and related stock indices.


Stock: NEO: MMED

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.